Literature DB >> 9711931

Low-molecular-weight heparins: an intriguing new twist with profound implications.

E M Antman, R Handin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9711931     DOI: 10.1161/01.cir.98.4.287

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

Review 1.  Critical review of unstable angina and non-ST elevation myocardial infarction.

Authors:  P J Sheridan; D C Crossman
Journal:  Postgrad Med J       Date:  2002-12       Impact factor: 2.401

Review 2.  Heparin dose during percutaneous coronary intervention: how low dare we go?

Authors:  G Niccoli; A P Banning
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

3.  Cost-effectiveness analysis of enoxaparin versus unfractionated heparin in patients with acute coronary syndrome in Poland: modelling study from the hospital perspective.

Authors:  Ewa Orlewska; Andrzej Budaj; Dariusz Tereszkowski-Kaminski
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

4.  The use of low molecular weight heparin to predict clinical outcome in patients with unstable angina that had undergone percutaneous coronary intervention.

Authors:  Young Joon Hong; Myung Ho Jeong; Seung Hyun Lee; Ok Young Park; Ju Han Kim; Weon Kim; Jay Young Rhew; Young Keun Ahn; Jeong Gwan Cho; Jong Chun Park; Soon Pal Suh; Byoung Hee Ahn; Sang Hyung Kim; Jung Chaee Kang
Journal:  Korean J Intern Med       Date:  2003-09       Impact factor: 2.884

5.  Safety and Efficacy of Low Molecular Weight Heparin for Thromboprophylaxis in the Elderly: A Network Meta-Analysis of Randomized Clinical Trials.

Authors:  Hui-Qin Yang; Man-Cang Liu; Wen-Jun Yin; Ling-Yun Zhou; Xiao-Cong Zuo
Journal:  Front Pharmacol       Date:  2021-12-10       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.